or Try an Advanced Search...

    Fatty Liver Stocks List

    Symbol Grade Name % Change
    GALT C Galectin Therapeutics Inc. -3.37
    GLMD F Galmed Pharmaceuticals Ltd. -5.41
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Cancer Acid Alcohol Alzheimer's Disease Combination Therapy Diabetes Fatty Acids Fatty Liver Disease Fibrotic Disease Galectin Galectin 3 Galecto Biotech Hepatitis Hepatology Hyperlipidemia Lactose Lectins Lipid Liver Disease Liver Fibrosis

    Related ETFs - A few ETFs which own one or more of the above listed Fatty Liver stocks.

    Symbol Grade Name Weight
    MEDX F Horizon Kinetics Medical ETF 0.89
    IWC B iShares Microcap ETF 0.01
    VTWG B Vanguard Russell 2000 Growth ETF 0.0
    UWM C ProShares Ultra Russell2000 0.0
    VTI A Vanguard Total Stock Market ETF 0.0
    View all Fatty Liver ETFs...
    Compare ETFs
    Compare IWC to UWM Compare IWC to VTWG Compare MEDX to VTWG

        Fatty Liver Stocks Recent News

        Date Stock Title
        Nov 18 GALT Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
        Nov 15 GLMD Galmed Pharmaceuticals: Q3 Earnings Snapshot
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Cancer Acid Alcohol Alzheimer's Disease Combination Therapy Diabetes Fatty Acids Fatty Liver Disease Fibrotic Disease Galectin Galectin 3 Galecto Biotech Hepatitis Hepatology Hyperlipidemia Lactose Lectins Lipid Liver Disease Liver Fibrosis
        Fatty Liver

        Fatty liver is a condition in which fat accumulates in the liver cells. It is usually caused by excessive alcohol consumption, but can also be caused by obesity, diabetes, high cholesterol, and certain medications. Fatty liver can lead to inflammation and scarring of the liver, which can lead to cirrhosis and liver failure.

        Browse All Tags